Verbist L, Verhaegen J
Klinisch Laboratorium Bacteriologie, Universitaire Ziekenhuizen, Leuven.
Acta Clin Belg. 1990;45(2):113-9. doi: 10.1080/17843286.1990.11718075.
The in vitro activity of cefonicid compared to that of other antibiotics has been evaluated against 401 Enterobacteriaceae, 20 H. influenzae, 17 Branhamella catarrhalis and 71 staphylococci. Cefonicid was always more active than cefazolin, and usually more active than cefamandole and cefuroxime against susceptible gram-negative organisms (E. coli, P. mirabilis, Klebsiella, Shigella, Salmonella, H. influenzae). Cefonicid was ineffective against most strains of Enterobacter, Citrobacter, S. marcescens and M. morganii. Staphylococci were 6 to 8 times less susceptible to cefonicid than to the other cephalosporins.
已针对401株肠杆菌科细菌、20株流感嗜血杆菌、17株卡他莫拉菌和71株葡萄球菌评估了头孢尼西与其他抗生素相比的体外活性。在针对敏感革兰氏阴性菌(大肠杆菌、奇异变形杆菌、克雷伯菌属、志贺菌属、沙门菌属、流感嗜血杆菌)时,头孢尼西的活性始终高于头孢唑林,且通常高于头孢孟多和头孢呋辛。头孢尼西对大多数阴沟肠杆菌、柠檬酸杆菌、粘质沙雷菌和摩根菌菌株无效。葡萄球菌对头孢尼西的敏感性比对其他头孢菌素低6至8倍。